PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31370809-5	2019	We aimed to examine cell specific MP profiles and concentrations of MPs expressing the atherosclerotic markers ICAM-1 and VCAM-1 after treatment with paricalcitol in patients with CKD stage 3-4.	paricalcitol	150-162	intercellular adhesion molecule 1	Homo sapiens	111-117	
31370809-11	2019	CONCLUSIONS: Treatment with paricalcitol reduces concentrations of ICAM-1 positive MPs.	paricalcitol	28-40	intercellular adhesion molecule 1	Homo sapiens	67-73